DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

Maxim Group Initiates Coverage On Armata Pharmaceuticals with Buy Rating, Announces $8 Price Target

Maxim Group initiates coverage on Armata Pharmaceuticals (AMEX:ARMP) with a Buy rating and a $8 price target.

Benzinga · 02/06/2020 13:07

Maxim Group initiates coverage on Armata Pharmaceuticals (AMEX:ARMP) with a Buy rating and a $8 price target.